Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing
ISSN:
1312-773X (Online)
Issue:
2017, vol. 23, issue 2
Subject Area:
Dental Medicine - Prosthetic Dentistry
-
DOI:
10.5272/jimab.2017232.1523
Published online: 26 April 2017
Original Article

J of IMAB 2017 Apr-Jun;23(2):1523-1526
AN OPTIMIZED GC-MS METHOD FOR IDENTIFICATION OF COCAINE AND ITS MAJOR METABOLITES
Georgi Bonchev



,
Laboratory of analytical toxicology, Military Medical Academy, Naval hospital - Varna, Bulgaria.
ABSTRACT:
Purpose: To develop a simple yet sensitive, reliable and robust method for qualitative determination of cocaine and a series of its tropane metabolites in biological samples (blood, urine, etc.). The method should be optimized for routine forensic expertise in analytical toxicology.
Material/Methods: Gas chromatography coupled with mass spectrometry (GC-MS) has been used as the method for analytical identification. Certified analytical standards were used as a reference material for validation.
Results: Sample preparation procedure has been simplified and organized in such a way, that only common reagents are required. Initial matrix purification is done by means of solid phase extraction (SPE), during which a carefully chosen set of simple solvents is applied. Additional derivatization (BSTFA/MTBSTFA) has been shown to be of a major importance for benzoylecgonine determination. Limit of detection (LOD) has been determined to be as low as 50 ng/mL for cocaine and 25 ng/mL for benzoylecgonine. Results are given within 90 minutes.
Keywords: cocaine, benzoylecgonine, solid phase extraction, analytical toxicology, drugs of abuse, forensic expertise,
- Download FULL TEXT /PDF 678 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Bonchev G. An optimized GC-MS method for identification of Cocaine and its major metabolites. J of IMAB. 2017 Jan-Mar;23(2):1523-1526. DOI: 10.5272/jimab.2017232.1523
Correspondence to: Georgi Bonchev, PhD, Head, Laboratory of Analytical Toxicology, Military Medical Academy, Naval Hospital – Varna; 3, Hristo Smirnenski Blvd., 9010 Varna, Bulgaria; E-mail: toxilab.varna@abv.bg
REFERENCES:
1. United Nations Office on Drugs and Crime. Statistics: Drug use and health consequences. Vienna: UNONDC; 2017. [cited 2017 February 10] [Internet ]
2. Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie. 2003 Jul;58(7):447-74. [PubMed ]
3. Niedbala RS, Kardos K, Fries T, Cannon A, Davis A. Immunoassay for detection of cocaine/metabolites in oral fluids. J Anal Toxicol. 2001 Jan-Feb;25(1):62-8. [PubMed ]
4. Carney S, Wolf CE, Tarnai-Moak L, Poklis A. Evaluation of two enzyme immunoassays for the detection of the cocaine metabolite benzoylecgonine in 1,398 urine specimens. J Clin Lab Anal. 2012 May;26(3):130–5. [PubMed] [CrossRef]
5. Barroso M, Gallardo E, Queiroz JA. Bioanalytical methods for the determination of cocaine and metabolites in human biological samples. Bioanalysis. 2009 Aug;1(5):977-1000. [PubMed ] [CrossRef]
6. Luzzi VI, Saunders AN, Koenig JW, Turk J, Lo SF, Garg UC, et al. Analytic performance of immunoassays for drugs of abuse below established cutoff values. Clin Chem. 2004 Apr;50(4):717-22. [PubMed] [CrossRef]
7. Wingert WE. Lowering cutoffs for initial and confirmation testing for cocaine and marijuana: large-scale study of effects on the rates of drug-positive results. Clin Chem. 1997 Jan;43(1):100-3. [PubMed ]
8. Cody JT, Foltz RL. GC/MS Analysis of body fluids for drugs of abuse. In: Forensic applications of mass spectrometry. Edited by Yinon J. CRC Press. November 29, 1994; Chapter 1:2-59. [Internet]
9. Valente MJ, Carvalho F, Bastos ML, Carvalho M, de Pinho PG. Chromatographic methodologies for analysis of cocaine and its metabolites in biological matrices. In: Gas Chromatography - Biochemicals, Narcotics and Essential Oils. Edited by Salih B, Çelikbıçak Ö. InTech. 2012. Chapter 8:163-94. [CrossRef ]
10. NIST Chemistry WebBook: Cocaine. NIST Mass Spectrometry Data Center. U.S. Secretary of Commerce, USA. 2016. [ Internet ]
11. Armbruster DA, Tillman MD, Hubbs LM. Limit of detection (LQD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem. 1994 Jul;40(7 Pt 1):1233-8. [PubMed ]
12. Lawson GM. Defining limit of detection and limit of quantitation as applied to drug of abuse testing: striving for a consensus. Clin Chem. 1994 Jul;40(7 Pt 1):1218-9. [PubMed ].
Received: 10 February 2017
Published online: 26 April 2017
back to Online Journal